Holmøy T - Search Results

1

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O. Kvistad S, et al. Among authors: holmoy t. Mult Scler. 2014 Dec;20(14):1833-40. doi: 10.1177/1352458514533843. Epub 2014 May 19. Mult Scler. 2014. PMID: 24842958

2

T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.

Holmøy T, Vandvik B, Vartdal F. Holmøy T, et al. Mult Scler. 2003 Jun;9(3):228-34. doi: 10.1191/1352458503ms906oa. Mult Scler. 2003. PMID: 12814167

3

Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells.

Holmøy T, Vartdal F. Holmøy T, et al. J Neurovirol. 2004 Feb;10(1):52-6. doi: 10.1080/13550280490261671. J Neurovirol. 2004. PMID: 14982728

4

Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein.

Holmøy T, Kvale EØ, Vartdal F. Holmøy T, et al. J Neurovirol. 2004 Oct;10(5):278-83. doi: 10.1080/13550280490499524. J Neurovirol. 2004. PMID: 15385250

5

Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis.

Holmøy T. Holmøy T. Med Hypotheses. 2008;70(1):66-9. doi: 10.1016/j.mehy.2007.04.030. Epub 2007 Jun 14. Med Hypotheses. 2008. PMID: 17574770

6

Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid.

Hestvik AL, Skorstad G, Price DA, Vartdal F, Holmoy T. Hestvik AL, et al. Among authors: holmoy t. Mult Scler. 2008 Jul;14(6):749-58. doi: 10.1177/1352458508089411. Mult Scler. 2008. PMID: 18611988 Clinical Trial.

7

25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis.

Holmøy T, Moen SM, Gundersen TA, Holick MF, Fainardi E, Castellazzi M, Casetta I. Holmøy T, et al. Mult Scler. 2009 Nov;15(11):1280-5. doi: 10.1177/1352458509107008. Epub 2009 Oct 6. Mult Scler. 2009. PMID: 19808741

8

Patient satisfaction in rehabilitation of patients with multiple sclerosis.

Holmøy T, Hanssen KT, Beiske AG. Holmøy T, et al. Tidsskr Nor Laegeforen. 2012 Mar 6;132(5):523-6. doi: 10.4045/tidsskr.11.1043. Tidsskr Nor Laegeforen. 2012. PMID: 22398768 Free article. English, Norwegian.

9

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.

Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM. Løken-Amsrud KI, et al. Among authors: holmoy t. Neurology. 2012 Jul 17;79(3):267-73. doi: 10.1212/WNL.0b013e31825fdf01. Epub 2012 Jun 13. Neurology. 2012. PMID: 22700809

10

Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients.

Saltytė Benth J, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T. Saltytė Benth J, et al. Among authors: holmoy t. Neuroepidemiology. 2012;39(2):84-93. doi: 10.1159/000339360. Epub 2012 Jul 17. Neuroepidemiology. 2012. PMID: 22814117 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page